{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:41:25Z","timestamp":1759455685587,"version":"build-2065373602"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.7759\/cureus.93737","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:19:18Z","timestamp":1759454358000},"source":"Crossref","is-referenced-by-count":0,"title":["Monocyte to High-Density Lipoprotein Ratio (MHR) and Monocyte to Lymphocyte Ratio (MLR) in Vitiligo: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Vaniyapilly  S","family":"Aathira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyaki","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02129-3","article-title":"Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary study","volume":"313","author":"Demirba\u015f A","year":"2021","unstructured":"Demirba\u015f A, Elmas \u00d6F, Atasoy M, T\u00fcrsen \u00dc, Lotti T. Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary study. Arch Dermatol Res. 2021, 313:491-8. 10.1007\/s00403-020-02129-3","journal-title":"Arch Dermatol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-010-0045-7","article-title":"Study of oxidative stress in vitiligo","volume":"26","author":"Jain A","year":"2011","unstructured":"Jain A, Mal J, Mehndiratta V, Chander R, Patra SK. Study of oxidative stress in vitiligo. Indian J Clin Biochem. 2011, 26:78-81. 10.1007\/s12291-010-0045-7","journal-title":"Indian J Clin Biochem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3029810","article-title":"Glutathione peroxidase level in patients with vitiligo: a meta-analysis","volume":"2016","author":"Xiao BH","year":"2016","unstructured":"Xiao BH, Shi M, Chen H, Cui S, Wu Y, Gao XH, Chen HD. Glutathione peroxidase level in patients with vitiligo: a meta-analysis. Biomed Res Int. 2016, 2016:3029810. 10.1155\/2016\/3029810","journal-title":"Biomed Res Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.739413","article-title":"Clinical significance of serum oxidative stress markers to assess disease activity and severity in patients with non-segmental vitiligo","volume":"9","author":"Li S","year":"2021","unstructured":"Li S, Dai W, Wang S, et al.. Clinical significance of serum oxidative stress markers to assess disease activity and severity in patients with non-segmental vitiligo. Front Cell Dev Biol. 2021, 9:739413. 10.3389\/fcell.2021.739413","journal-title":"Front Cell Dev Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15985","article-title":"More evidence for catalase as a pathogenetic cornerstone in vitiligo","volume":"177","author":"B\u00f6hm M","year":"2017","unstructured":"B\u00f6hm M. More evidence for catalase as a pathogenetic cornerstone in vitiligo. Br J Dermatol. 2017, 177:1477. 10.1111\/bjd.15985","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2009.05338.x","article-title":"High-density lipoprotein: a potent inhibitor of inflammation","volume":"37","author":"Murphy AJ","year":"2010","unstructured":"Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010, 37:710-8. 10.1111\/j.1440-1681.2009.05338.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.253","article-title":"ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation","volume":"4","author":"Chen S","year":"2013","unstructured":"Chen S, Su Y, Wang J. ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation. Cell Death Dis. 2013, 4:e722. 10.1038\/cddis.2013.253","journal-title":"Cell Death Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.02.008","article-title":"Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis","volume":"95","author":"Sirin MC","year":"2020","unstructured":"Sirin MC, Korkmaz S, Erturan I, Filiz B, Aridogan BC, Cetin ES, Yildirim M. Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis. An Bras Dermatol. 2020, 95:575-82. 10.1016\/j.abd.2020.02.008","journal-title":"An Bras Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0003319717704748","article-title":"Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Beh\u00e7et disease","volume":"69","author":"Acikgoz N","year":"2018","unstructured":"Acikgoz N, Kurto\u011flu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Beh\u00e7et disease. Angiology. 2018, 69:65-70. 10.1177\/0003319717704748","journal-title":"Angiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13639","article-title":"Investigation of monocyte HDL ratio as an indicator of inflammation and complete blood count parameters in patients with acne vulgaris","volume":"74","author":"Turkmen D","year":"2020","unstructured":"Turkmen D, Altunisik N, Sener S. Investigation of monocyte HDL ratio as an indicator of inflammation and complete blood count parameters in patients with acne vulgaris. Int J Clin Pract. 2020, 74:e13639. 10.1111\/ijcp.13639","journal-title":"Int J Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.30733\/std.2023.01684","article-title":"Monocyte\/high-density lipoprotein ratio: an indicator of oxidative stress and disease severity in lichen planus patients","volume":"40","author":"Temiz SA","year":"2024","unstructured":"Temiz SA, Daye M. Monocyte\/high-density lipoprotein ratio: an indicator of oxidative stress and disease severity in lichen planus patients. Selcuk Med J. 2024, 40:29-33. 10.30733\/std.2023.01684","journal-title":"Selcuk Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.32322\/jhsm.1348381","article-title":"Evaluation of monocyte to high-density lipoprotein cholesterol ratio and other inflammatory markers in hidradenitis suppurativa: a case-control study","volume":"6","author":"Utlu Z","year":"2023","unstructured":"Utlu Z, \u00d6zbek \u015eebin S, Metin N. Evaluation of monocyte to high-density lipoprotein cholesterol ratio and other inflammatory markers in hidradenitis suppurativa: a case-control study. J Health Sci Med. 2023, 6:1200-4. 10.32322\/jhsm.1348381","journal-title":"J Health Sci Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0404a18","article-title":"Vitiligo extent tensity index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo","volume":"4","author":"Feily A","year":"2014","unstructured":"Feily A. Vitiligo extent tensity index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo. Dermatol Pract Concept. 2014, 4:81-4. 10.5826\/dpc.0404a18","journal-title":"Dermatol Pract Concept"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.4.407","article-title":"Association of the K\u00f6bner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris","volume":"135","author":"Njoo MD","year":"1999","unstructured":"Njoo MD, Das PK, Bos JD, Westerhof W. Association of the K\u00f6bner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999, 135:407-13. 10.1001\/archderm.135.4.407","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-014-0730-1","article-title":"Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease","volume":"46","author":"Kanbay M","year":"2014","unstructured":"Kanbay M, Solak Y, Unal HU, et al.. Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014, 46:1619-25. 10.1007\/s11255-014-0730-1","journal-title":"Int Urol Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56034","article-title":"An evaluation of the hematological markers of systemic inflammation and oxidative stress in vitiligo: a case-control study","volume":"16","author":"Temel B","year":"2024","unstructured":"Temel B, Orenay O, Karaosmanoglu N. An evaluation of the hematological markers of systemic inflammation and oxidative stress in vitiligo: a case-control study. Cureus. 2024, 16:e56034. 10.7759\/cureus.56034","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_124_18","article-title":"Clinico-epidemiological profile of patients with vitiligo: a retrospective study from a tertiary care center of North India","volume":"10","author":"Mahajan VK","year":"2019","unstructured":"Mahajan VK, Vashist S, Chauhan PS, Mehta KI, Sharma V, Sharma A. Clinico-epidemiological profile of patients with vitiligo: a retrospective study from a tertiary care center of North India. Indian Dermatol Online J. 2019, 10:38-44. 10.4103\/idoj.IDOJ_124_18","journal-title":"Indian Dermatol Online J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_822_19","article-title":"A nationwide, multicentric case-control study on vitiligo (MEDEC-V) to elicit the magnitude and correlates","volume":"65","author":"Sarma N","year":"2020","unstructured":"Sarma N, Chakraborty S, Poojary S, et al.. A nationwide, multicentric case-control study on vitiligo (MEDEC-V) to elicit the magnitude and correlates. Indian J Dermatol. 2020, 65:473-82. 10.4103\/ijd.IJD_822_19","journal-title":"Indian J Dermatol"},{"key":"ref19","article-title":"Pre and post treatment assessment of inflammatory markers in active vitiligo patients: a prospective study from a large tertiary center in Northern India","volume":"29","author":"Vivin P","year":"2022","unstructured":"Vivin P, Taru G, Ram C, Deepika Y, Kumar MA. Pre and post treatment assessment of inflammatory markers in active vitiligo patients: a prospective study from a large tertiary center in Northern India. Gulf J Dermatol Venereol. 2022, 29:10-6.","journal-title":"Gulf J Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1402a75","article-title":"Impact of vitiligo on quality of life in patients of skin of color and its correlation with clinical severity assessment scores utilizing disease specific scores: a cross-sectional study","volume":"14","author":"Awal G","year":"2024","unstructured":"Awal G, Kaur N, Singh G, Sharma N. Impact of vitiligo on quality of life in patients of skin of color and its correlation with clinical severity assessment scores utilizing disease specific scores: a cross-sectional study. Dermatol Pract Concept. 2024, 14:10.5826\/dpc.1402a75","journal-title":"Dermatol Pract Concept"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2017.71114","article-title":"Neutrophil to lymphocyte ratio in patients with vitiligo","volume":"34","author":"Solak B","year":"2017","unstructured":"Solak B, Dikicier BS, Cosansu NC, Erdem T. Neutrophil to lymphocyte ratio in patients with vitiligo. Postepy Dermatol Alergol. 2017, 34:468-70. 10.5114\/ada.2017.71114","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/407128-monocyte-to-high-density-lipoprotein-ratio-mhr-and-monocyte-to-lymphocyte-ratio-mlr-in-vitiligo-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:19:19Z","timestamp":1759454359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/407128-monocyte-to-high-density-lipoprotein-ratio-mhr-and-monocyte-to-lymphocyte-ratio-mlr-in-vitiligo-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.93737","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}